Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - March 2013


Mass Spec 2013

06 Mar 2013 - 07 Mar 2013 - Singapore



Bookmark and Share


Mass Spectrometry 2013 is a world-class international conference and exhibition, covering fundamentals, best practice and applications in mass spectrometry and mass spectrometry coupled techniques. Taking place 6-7 March, 2013 at the state-of-the-art Biopolis, Singapore, this educational event offers you the chance to learn from some of the world's top experts in the use of mass spectrometry in a format that offers solutions to routine analytical challenges across industry sectors.

What Does it Cover
The two-day programme has been developed to cover the basics, method development, best practice and analysis of results vital to efficient and robust MS use. Presentations include:

  • LC for LC-MS: Exploiting the Power of Scouting Gradients
  • LC for LC-MS: Considerations When Designing an HPLC Method for Use with LC-MS
  • Hyphenating GC-MS: the GC Perspective
  • Hyphenating GC-MS: the MS Perspective
  • Fundamentals of the Electrospray Process
  • Choosing Interface and Mass Spectrometer Settings for LC-MS
  • Operational Description of an APCI LC-MS Interface
  • Ion Suppression and Other Performance Problems in Electrospray
  • Using MS to Identify Unknowns and Known Unknowns Using Databases and Third Party Mass Spectral Software
  • Applications of IMS TOF in Drug Discovery
  • Fundamentals and Applications of FT ICR Mass Spectrometry
  • Mass Spectrometry Imaging and In situ Ambient MS
  • Selected Ion Flow Tube Mass Spectrometry
  • Imaging Mass Spectrometry Data Analysis
  • Recent Advances and Applications in DART Techniques
  • Exploiting High Resolution Mass Spectrometry for Macromolecule and Biomolecule Analysis
  • Mass Spectrometry for Biopolymer/BioPharmaceutical Characterization
  • Protein and Carbohydrate Sequencing using Mass Spectrometry



Further information
Scientific News
Long Telomeres Associated with Increased Lung Cancer Risk
Genetic predisposition for long telomeres predicts increased lung adenocarcinoma risk.
Expanding the Brain
A team of researchers has identified more than 40 new “imprinted” genes, in which either the maternal or paternal copy of a gene is expressed while the other is silenced.
Identifying a Key Growth Factor in Cell Proliferation
Researchers discover that aspartate is a limiter of cell proliferation.
Study Uncovers Target for Preventing Huntington’s Disease
Scientists from Cardiff University believe that a treatment to prevent or delay the symptoms of Huntington’s disease could now be much closer, following a major breakthrough.
The Genetic Roots of Adolescent Scoliosis
Scientists at the RIKEN Center for Integrative Medical Sciences in collaboration with Keio University in Japan have discovered a gene that is linked to susceptibility of Scoliosis.
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
New Tool Uses 'Drug Spillover' to Match Cancer Patients with Treatments
Researchers have developed a new tool that improves the ability to match drugs to disease: the Kinase Addiction Ranker (KAR) predicts what genetics are truly driving the cancer in any population of cells and chooses the best "kinase inhibitor" to silence these dangerous genetic causes of disease.
Understanding the Molecular Origin of Epigenetic Markers
Researchers at IRB Barcelona discover the molecular mechanism that determines how epigenetic markers influence gene expression.
New Tech Enables Epigenomic Analysis with a Mere 100 Cells
A new technology that will dramatically enhance investigations of epigenomes, the machinery that turns on and off genes and a very prominent field of study in diseases such as stem cell differentiation, inflammation and cancer has been developed by researchers at Virginia Tech.
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!